Tumor Microenvironment in Ovarian Cancer: Function and Therapeutic Strategy
Author:
Publisher
Frontiers Media SA
Subject
Cell Biology,Developmental Biology
Reference287 articles.
1. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.;Aghajanian;J. Clin. Oncol.,2012
2. Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer.;Aghajanian;Gynecol. Oncol.,2015
3. Tumor-infiltrating human CD4((+) regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity.;Ahmadzadeh;Sci. Immunol.,2019
4. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.;Ahmed;Semin. Cancer Biol.,2018
5. Angiogenic signalling pathways.;Ahmed;Methods Mol. Biol.,2009
Cited by 126 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential;Non-coding RNA Research;2024-12
2. Multicompartmentalized Microvascularized Tumor-on-a-Chip to Study Tumor-Stroma Interactions and Drug Resistance in Ovarian Cancer;Cellular and Molecular Bioengineering;2024-09-14
3. Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma;Frontiers in Immunology;2024-09-09
4. Ecological and evolutionary dynamics to design and improve ovarian cancer treatment;Clinical and Translational Medicine;2024-08-29
5. Molecular biology as a driver in therapeutic choices for ovarian cancer;International Journal of Gynecologic Cancer;2024-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3